View drug registration information details.


ItemsRegistration information
ID2097
No2097
Brand NameOSSIFIX
IngredientsCALCIUM CARBONATE USP 1.250 MG EQ.TO ELEMENTAL CALCIUM 500 MG, MAGNESIUM OXIDE USP 50 MG, VITAMINE D3 BP 250 IU, ZINC SULPHATE MONOHYDRATE USP 35 MG, LYSINE HYDROCHLORIDE USP 100MG
Dosage FormFILM COATED TABLET
Primary PackagingALU-PVC BLISTERPACK
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 10 X 1 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsPREDIALYSIS PATIENTS: IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULANT METABOLIC BONE DISEASE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENALFAILURE NOT YET ON DIALYSIS. DIALYSIS PATIENTS: FOR MANAGEMENT OF HYPOCALCEMIA AND THE RESULTANT METABOLIC BONE DISEASE IN PATIENTS UNDERGOING CHRONIC RENAL DIALYSIS
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionRED COLOUR OBLONG BICONVEX SHAPED FILM COATED TABLET. ONE SIDE PLAIN AND OTHER SIDE SCORED
Note
License OwnerPALAMY PHARMA CO., LTD
ManufacturerZEE LABOBORATORIES
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 2732/06
FDD Registration Date07-FEB-2024
Expiry Date06-FEB-2027

Back to drug list